| Indapamide |
2419/04,07,2008 |
Mivara SR, Prolonged release tablet, 1.5, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Stada Arneimittel AG, Germany; Centrafarm Services B.v. - The Netherland; Stada Production Ireland Ltd. - Ireland |
4.11 |
0.82 |
4.93 |
9% |
0.37 |
4.48 |
0.9 |
5.38 |
22% |
0.9 |
5.38 |
1.08 |
6.46 |
корекц. КЦ-778/07.04.2009 |
КЦ-759/31.03.2009 |
18.04.2009 |
18.04.2009 |
Неактивен |
1629 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Suspension for injection, 100 IU/ml - 3 ml, -, Pack: 5 cartridges |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.31 |
7.86 |
47.17 |
4% |
1.57 |
40.88 |
8.18 |
49.06 |
16% |
6.29 |
47.17 |
9.43 |
56.6 |
Протокол №200/01.12.2016 |
НСР-6606/01.07.2015; НСР-10333/15.09.2016 |
01.10.2016 |
02.12.2016 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Suspension for injection, 100 IU/ml - 3 ml, -, Pack: 5 cartridges |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
38.2 |
7.64 |
45.84 |
4% |
1.53 |
39.73 |
7.95 |
47.68 |
16% |
6.11 |
45.84 |
9.17 |
55.01 |
Протокол №200/01.12.2016 |
НСР-6606/01.07.2015; НСР-10333/15.09.2016; НСР-14764/22.12.2017; НСР-18136/07.03.2019 |
22.03.2019 |
02.04.2019 |
Активен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Suspension for injection, 100 IU/ml - 3 ml, -, Pack: 5 cartridges |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
38.28 |
7.66 |
45.94 |
4% |
1.53 |
39.81 |
7.96 |
47.77 |
16% |
6.12 |
45.93 |
9.19 |
55.12 |
Протокол №200/01.12.2016 |
НСР-6606/01.07.2015; НСР-10333/15.09.2016; НСР-14764/22.12.2017 |
12.01.2018 |
02.02.2018 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.31 |
7.86 |
47.17 |
4% |
1.57 |
40.88 |
8.18 |
49.06 |
16% |
6.29 |
47.17 |
9.43 |
56.6 |
|
НСР-6606/01.07.2015; НСР-10333/15.09.2016 |
02.11.2016 |
02.11.2016 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.53 |
7.91 |
47.44 |
4% |
1.58 |
41.11 |
8.22 |
49.33 |
16% |
6.32 |
47.43 |
9.49 |
56.92 |
|
НСР-6606/01.07.2015 |
17.07.2015 |
17.07.2015 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.53 |
7.91 |
47.44 |
4% |
1.58 |
41.11 |
8.22 |
49.33 |
16% |
6.32 |
47.43 |
9.49 |
56.92 |
|
НСР-6606/01.07.2015 |
17.07.2015 |
17.07.2015 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
39.94 |
7.99 |
47.93 |
4% |
1.6 |
41.54 |
8.31 |
49.85 |
16% |
6.39 |
47.93 |
9.59 |
57.52 |
|
НСР-3423/30.04.2014 |
22.05.2014 |
22.05.2014 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé , Дания; Novo Nordisk Production SAS 45, Франция |
40.8 |
8.16 |
48.96 |
4% |
1.63 |
42.43 |
8.49 |
50.92 |
16% |
6.53 |
48.96 |
9.79 |
58.75 |
|
НСР-1035/23.08.2013 |
17.09.2013 |
17.09.2013 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
Novo Nordisk A/S Novo Allé DK-2880 Bagsværd, Дания; Novo Nordisk Production SAS 45, Avenue d’Orléans F-28002 Chartres, Франция |
40.82 |
8.16 |
48.98 |
4% |
1.63 |
42.45 |
8.49 |
50.94 |
16% |
6.53 |
48.98 |
9.8 |
58.78 |
корекц. решение КЦРР-1762/04.12.2012 |
КЦРР-1341/24.08.2012 |
12.12.2012 |
12.12.2012 |
Неактивен |
2777 |
| Insulin (human) |
EU/1/02/231/012 |
Mixtard 30 Penfill, Solution for injection, 300, IU, Pack: 5 |
Novo Nordisk A/S, Дания |
1)Novo Nordisk A/S Novo Allé DK-2880 Bagsværd, Дания 2)Novo Nordisk Production SAS 45, Avenue d’Orléans F-28002 Chartres, Франция |
41.74 |
8.35 |
50.09 |
4% |
1.67 |
43.41 |
8.68 |
52.09 |
16% |
6.68 |
50.09 |
10.02 |
60.11 |
|
КЦ-730/18.03.2009 |
02.04.2009 |
02.04.2009 |
Неактивен |
2777 |
| Measles, mumps and rubella vaccine (live) |
EU/1/06/337/011 |
M-M-RVAXPRO, Powder and solvent for suspension for injection, 0,5 ml, -, Pack: 1 vial + 1 pre-filled syringe + 2 needles |
MSD VACCINS, Lyon, Франция |
Merck Sharp & Dohme B.V., Холандия |
14.96 |
2.99 |
17.95 |
6% |
0.9 |
15.86 |
3.17 |
19.03 |
18% |
2.69 |
18.55 |
3.71 |
22.26 |
промяна на обстоятелства НСР-12916/08.06.2017 |
НСР-2854/21.02.2014 |
07.03.2014 |
02.07.2017 |
Активен |
2517 |
| Measles, mumps and rubella vaccine (live) |
EU/1/06/337/011 |
M-M-RVAXPRO, Powder and solvent for suspension for injection, 0,5 ml, -, Pack: 1 vial + 1 pre-filled syringe + 2 needles |
Sanofi Pasteur MSD, SNC, Франция |
Merck Sharp & Dohme B.V., Холандия |
14.96 |
2.99 |
17.95 |
6% |
0.9 |
15.86 |
3.17 |
19.03 |
18% |
2.69 |
18.55 |
3.71 |
22.26 |
|
НСР-2854/21.02.2014 |
07.03.2014 |
07.03.2014 |
Неактивен |
2517 |
| Moclobemide |
II-3497/13,11,2008 |
Moclobemide Sopharma, Film coated tablet, 150, mg, Pack: 30 |
Софарма АД, България |
СОФАРМА АД |
8.24 |
1.65 |
9.89 |
9% |
0.74 |
8.98 |
1.8 |
10.78 |
22% |
1.81 |
10.79 |
2.16 |
12.95 |
цената се заличава КЦРР-900/28.06.2012 |
КЦ-879/12.05.2009 |
29.05.2009 |
29.05.2009 |
Заличен |
726 |
| Fluphenazine |
20010044 |
MODITEN DEPO, Solution for injection, 25 mg/ml - 1 ml, mg, Pack: 5 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
19.56 |
3.91 |
23.47 |
6% |
1.17 |
20.73 |
4.15 |
24.88 |
18% |
3.52 |
24.25 |
4.85 |
29.1 |
Промяна на обстоятелства НСР-11178/08.12.2016 |
КЦ-412/07.01.2009; НСР-19868/27.09.2019 |
12.10.2019 |
02.11.2019 |
Активен |
440 |
| Fluphenazine |
20010044 |
MODITEN DEPO, Solution for injection, 25 mg/ml - 1 ml, mg, Pack: 5 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
13.06 |
2.61 |
15.67 |
6% |
0.78 |
13.84 |
2.77 |
16.61 |
18% |
2.35 |
16.19 |
3.24 |
19.43 |
Промяна на обстоятелства НСР-11178/08.12.2016 |
КЦ-412/07.01.2009 |
02.02.2009 |
02.01.2017 |
Неактивен |
440 |
| Fluphenazine |
II-12995/17.05.2006 |
MODITEN DEPO solution for injection 25 mg/ml x 5, Solution for injection, 25, mg/ml, Pack: 5 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Slovenia |
13.06 |
2.61 |
15.67 |
6% |
0.78 |
13.84 |
2.77 |
16.61 |
18% |
2.35 |
16.19 |
3.24 |
19.43 |
|
КЦ-412/07.01.2009 |
02.02.2009 |
02.02.2009 |
Неактивен |
440 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
8.19 |
1.64 |
9.83 |
7% |
0.57 |
8.76 |
1.75 |
10.51 |
20% |
1.64 |
10.4 |
2.08 |
12.48 |
|
НСР-6679/09.07.2015 |
25.07.2015 |
25.07.2015 |
Активен |
2724 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
8.19 |
1.64 |
9.83 |
7% |
0.57 |
8.76 |
1.75 |
10.51 |
20% |
1.64 |
10.4 |
2.08 |
12.48 |
|
НСР-6679/09.07.2015 |
25.07.2015 |
25.07.2015 |
Неактивен |
2724 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
8.68 |
1.74 |
10.42 |
7% |
0.61 |
9.29 |
1.86 |
11.15 |
20% |
1.74 |
11.03 |
2.21 |
13.24 |
|
НСР-3310/24.04.2014 |
08.05.2014 |
08.05.2014 |
Неактивен |
2724 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.2 |
2.24 |
13.44 |
|
НСР-644/29.07.2013 |
26.08.2013 |
26.08.2013 |
Неактивен |
2724 |
| Trimetazidine |
20110539 |
Moduxin MR, Prolonged release tablet, 35, mg, Pack: 60 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
10.37 |
2.07 |
12.44 |
6% |
0.62 |
10.99 |
2.2 |
13.19 |
18% |
1.87 |
12.86 |
2.57 |
15.43 |
|
КЦРР-1572/05.11.2012 |
22.11.2012 |
22.11.2012 |
Неактивен |
2724 |
| Moexipril |
II-1319/21.12.2007 |
Moex, Film coated tablet, 7.5, mg, Pack: 30 |
UCB Pharma GmbH, Германия |
AESICA Pharmaceuticals GmbH, Германия |
7 |
1.4 |
8.4 |
7% |
0.49 |
7.49 |
1.5 |
8.99 |
20% |
1.4 |
8.89 |
1.78 |
10.67 |
промяна на обстоятелства НСР-6248/21.05.2015 |
КЦ-520/09.02.2009; НСР-11374/30.12.2016 |
02.03.2009 |
02.02.2017 |
Заличен |
509 |
| Moexipril |
II-1319/21.12.2007 |
Moex, Film coated tablet, 7.5, mg, Pack: 30 |
UCB Pharma GmbH, Германия |
AESICA Pharmaceuticals GmbH, Германия |
7 |
1.4 |
8.4 |
7% |
0.49 |
7.49 |
1.5 |
8.99 |
20% |
1.4 |
8.89 |
1.78 |
10.67 |
промяна на обстоятелства НСР-6248/21.05.2015 |
КЦ-520/09.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
509 |
| Moexipril |
II-1320/21.12.2007 |
Moex, Film coated tablet, 15, mg, Pack: 30 |
UCB Pharma GmbH, Германия |
AESICA Pharmaceuticals GmbH, Германия |
13.32 |
2.66 |
15.98 |
6% |
0.8 |
14.12 |
2.82 |
16.94 |
18% |
2.4 |
16.52 |
3.3 |
19.82 |
промяна на обстоятелства НСР-6249/21.05.2015 |
КЦРР-1126/02.08.2012; НСР-11374/30.12.2016 |
14.09.2012 |
02.02.2017 |
Заличен |
1348 |